Rémi Buisson
@buissonlab.bsky.social
510 followers 310 following 33 posts
Associate Professor at University of California Irvine. APOBEC, innate immunity, DNA damage, RNA viruses, and scuba diving fanatic.
Posts Media Videos Starter Packs
buissonlab.bsky.social
Thanks for the great description of our recent study!
buissonlab.bsky.social
Many thanks to @pedroorteg.bsky.social for leading this work, and to @johnmaciejowski.bsky.social and the Abby Green Lab for their contributions to the story.
buissonlab.bsky.social
Today, we report that APOBEC3B targets unprotected single-stranded DNA at replication forks upon ATR inhibition, triggering a reaction cascade involving UNG2 and APE1 that leads to fork collapse and hyperactivation of PARP1, causing replication catastrophe.
www.science.org/doi/10.1126/...
Mechanism of DNA replication fork breakage and PARP1 hyperactivation during replication catastrophe
Upon ATR inhibition, APOBEC3B targets unprotected single-stranded DNA at replication forks, leading to fork breakage.
www.science.org
buissonlab.bsky.social
Thank you so much for this beautiful review of our paper!!
Reposted by Rémi Buisson
findmeinthelab.bsky.social
UCI Anteaters standing up for science today!
Reposted by Rémi Buisson
cejkalab.bsky.social
Very sad to read about the science funding situation in the US at the moment. I am waiting for some funding decisions in the coming weeks, but I will likely have opening(s) in my lab in Switzerland in the coming weeks (PhD student/postdoc). As a PhD candidate, you need to have a Master's degree.
Reposted by Rémi Buisson
freudlab.bsky.social
Happy to report the 2025/05 NIH Biochemical and Cellular Oncogenesis (BCO) study section meeting has been rescheduled for late April. Just FYI.
freudlab.bsky.social
The 2025/05 NIH Biochemical and Cellular Oncogenesis (BCO) study section meeting that was supposed to happen tomorrow has been rescheduled to a later date, to be determined. Just FYI for folks wondering. This is so disheartening.
Reposted by Rémi Buisson
freudlab.bsky.social
The 2025/05 NIH Biochemical and Cellular Oncogenesis (BCO) study section meeting that was supposed to happen tomorrow has been rescheduled to a later date, to be determined. Just FYI for folks wondering. This is so disheartening.
buissonlab.bsky.social
So frustrating! For both reviewers and applicants…. So much work for nothing….
buissonlab.bsky.social
Our findings provide an alternative mechanism for damaged cells with impaired transcription to initiate an inflammatory response without relying on their own gene expression, a necessary step that injured cells depend on during canonical innate immune responses.
buissonlab.bsky.social
Thank you very much! I am glad you liked our story!
buissonlab.bsky.social
Congratulation 🥳
buissonlab.bsky.social
Our detailed protocol revealing our secret to performing perfect in vitro APOBEC deaminase reactions on DNA substrates at near-nucleotide resolution. authors.elsevier.com/a/1kDyIHRzCU...
authors.elsevier.com
buissonlab.bsky.social
Félicitation !!!🥳
buissonlab.bsky.social
We propose that both PACT and ADAR1 act as essential barriers against PKR, creating a threshold of tolerable levels to endogenous dsRNA in cells without activating PKR-mediated translation shutdown and cell death.
buissonlab.bsky.social
Simultaneous deletion of PACT and ADAR1 results in synthetic lethality, which can be fully rescued in PKR-deficient cells. This suggests PACT cooperates with ADAR1 to suppress PKR activation from self-dsRNAs in uninfected cells.
buissonlab.bsky.social
Our Alphafold 3 modeling analysis of PACT reveals the formation of a dimer that surrounds dsRNA, blocking access to both sides of the dsRNA and thereby preventing PKR activation.
buissonlab.bsky.social
We find that cells deficient for PACT hyperactivate PKR in response to several different RNA viruses, raising the question of why cells need to limit PKR activity? We show that it is critical to prevent PKR activation from self-dsRNA.